Elevated erythropoietin mRNA and protein concentrations in the developing human eye

Area of Science:

• Ophthalmology
• Developmental Biology
• Molecular Biology

Background:

• Erythropoietin (Epo) is known for its roles in red blood cell production, neuroprotection, and blood vessel formation.
• Elevated Epo levels are observed in adult diabetic retinopathy, but its role in premature infants' retinal development is unclear.

Purpose of the Study:

• To investigate the presence and concentration of Epo and its mRNA in the developing human eye.
• To determine if Epo levels change with gestational age in fetal serum and vitreous.

Main Methods:

• Real-time polymerase chain reaction was used to quantify Epo and hypoxia-inducible factor-1alpha (HIF) mRNA in fetal retinas.
• Enzyme-linked immunosorbent serologic assay was employed to measure Epo protein levels in fetal serum and vitreous samples.
• Samples were collected from fetuses between 12 and 24 weeks of gestation.

Main Results:

• Epo mRNA levels in the retina increased with advancing gestational age, while HIF mRNA levels remained constant.
• Epo protein concentrations rose with increasing gestation in both fetal serum and vitreous.
• Epo levels were consistently higher in the vitreous compared to serum across all gestational groups.

Conclusions:

• Epo is present in the developing human eye, with increasing concentrations as gestation progresses.
• Higher vitreous Epo levels suggest a potential role in normal retinal vascular development.
• Altered Epo production after preterm birth may influence retinal vascularization in premature infants.